Current Status on CM for Biologics: Development to Clinical

Description

Current Status on CM for Biologics: Development to Clinical

Speakers will provide insights on the current stage of deployment of CM for biological molecule clinical manufacturing from the point of view of process technologies, facility assets, and manufacturing operations. Examples of successes as well as challenges encountered will be shared.

• The Biopharmaceutical Industry Emerging Continuous and Integrated Platform for Recombinant Protein Jon Coffman, PhD, Senior Director of Bioprocess Technology and Engineering AstraZeneca
• Perspectives on the Development of Continuous Manufacturing for Biological Products
  Mark Brower, Principal Scientist
  Merck
• Novel Technologies to Enable Continuous Manufacturing of Biologics
  Govind Rao, PhD, Director, Center for Advanced Sensor Technology
  University of Maryland, Baltimore County

Moderator(s):

• Antonio R. Moreira, PhD, Vice Provost, Academic Affairs, University of Maryland, Baltimore County

Speaker(s):

• Jon Coffman, PhD, Senior Director of Bioprocess Technology and Engineering, AstraZeneca
• Mark Brower, Principal Scientist, Merck & Co., Inc.
• Govind Rao, PhD, Professor & Director, Center for Advanced Sensor Technology, University of Maryland, Baltimore County